NVNO vs. QTUM
NVNO (enVVeno Medical Corporation) is a stock, while QTUM (Defiance Quantum ETF) is Technology Equities fund tracking the BlueStar Machine Learning and Quantum Computing Index. Over the past 5 years, NVNO returned -45.07%/yr vs 28.96%/yr for QTUM. At a 0.24 correlation, their price movements are largely independent.
Performance
NVNO vs. QTUM - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, NVNO achieves a -4.26% return, which is significantly lower than QTUM's 52.13% return.
NVNO
- 1D
- 0.38%
- 1M
- 3.56%
- YTD
- -4.26%
- 6M
- -20.84%
- 1Y
- -91.65%
- 3Y*
- -53.33%
- 5Y*
- -45.07%
- 10Y*
- —
QTUM
- 1D
- -0.76%
- 1M
- 19.63%
- YTD
- 52.13%
- 6M
- 48.25%
- 1Y
- 92.25%
- 3Y*
- 52.13%
- 5Y*
- 28.96%
- 10Y*
- —
NVNO vs. QTUM - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
NVNO enVVeno Medical Corporation | -4.26% | -89.38% | -41.25% | 0.78% | -22.61% | -23.82% | -37.09% | -62.71% | -29.09% |
QTUM Defiance Quantum ETF | 52.13% | 36.65% | 50.54% | 39.86% | -28.80% | 35.18% | 42.05% | 47.99% | -19.02% |
Correlation
The correlation between NVNO and QTUM is 0.26, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.26 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.25 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.27 |
Correlation (All Time) Calculated using the full available price history since Sep 6, 2018 | 0.24 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
NVNO vs. QTUM — Risk / Return Rank
NVNO
QTUM
NVNO vs. QTUM - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for enVVeno Medical Corporation (NVNO) and Defiance Quantum ETF (QTUM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| NVNO | QTUM | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -4.30 | ||
| Sortino ratioReturn per unit of downside risk | -5.59 | ||
| Omega ratioGain probability vs. loss probability | 0.77 | 1.54 | -0.77 |
| Calmar ratioReturn relative to maximum drawdown | -0.96 | 6.08 | -7.04 |
| Martin ratioReturn relative to average drawdown | -1.13 | 22.92 | -24.05 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| NVNO | QTUM | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.77 | 3.53 | -4.30 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.56 | 1.10 | -1.65 |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.57 | 1.07 | -1.64 |
Drawdowns
NVNO vs. QTUM - Drawdown Comparison
The maximum NVNO drawdown since its inception was -99.81%, which is greater than QTUM's maximum drawdown of -38.45%. Use the drawdown chart below to compare losses from any high point for NVNO and QTUM.
Loading charts...
Drawdown Indicators
| NVNO | QTUM | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.81% | -38.45% | -61.36% |
Max Drawdown (1Y)Largest decline over 1 year | -95.28% | -15.26% | -80.02% |
Max Drawdown (3Y)Largest decline over 3 years | -96.27% | -25.39% | -70.88% |
Max Drawdown (5Y)Largest decline over 5 years | -97.66% | -38.45% | -59.21% |
Current DrawdownCurrent decline from peak | -99.77% | -1.35% | -98.42% |
Average DrawdownAverage peak-to-trough decline | -89.97% | -8.25% | -81.72% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 81.03% | 4.04% | +76.99% |
Volatility
NVNO vs. QTUM - Volatility Comparison
enVVeno Medical Corporation (NVNO) has a higher volatility of 16.83% compared to Defiance Quantum ETF (QTUM) at 9.78%. This indicates that NVNO's price experiences larger fluctuations and is considered to be riskier than QTUM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| NVNO | QTUM | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 16.83% | 9.78% | +7.05% |
Volatility (6M)Calculated over the trailing 6-month period | 62.44% | 20.32% | +42.12% |
Volatility (1Y)Calculated over the trailing 1-year period | 119.68% | 26.27% | +93.41% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 81.37% | 26.56% | +54.81% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 93.70% | 27.16% | +66.54% |
Dividends
NVNO vs. QTUM - Dividend Comparison
NVNO has not paid dividends to shareholders, while QTUM's dividend yield for the trailing twelve months is around 0.70%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
NVNO enVVeno Medical Corporation | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
QTUM Defiance Quantum ETF | 0.70% | 1.01% | 0.61% | 0.81% | 1.46% | 0.48% | 0.42% | 0.61% | 0.21% |
Frequently Asked Questions
NVNO and QTUM have a correlation of 0.26, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
NVNO has higher volatility (16.83%) compared to QTUM (9.78%). In terms of maximum drawdown, NVNO dropped -99.81% vs QTUM's -38.45%.
QTUM currently has the higher Sharpe Ratio (3.53 vs -0.77), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for NVNO and QTUM
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer